Myectomy Safe in Older Patients With Obstructive HCM
Surgical myectomy was safe in older adults with obstructive hypertrophic cardiomyopathy despite varied morphological features and patient characteristics.
Read MoreNov 4, 2024
Surgical myectomy was safe in older adults with obstructive hypertrophic cardiomyopathy despite varied morphological features and patient characteristics.
Read MoreNov 4, 2024
Findings suggest a tailored, moderate-intensity exercise program can be safe and beneficial in carefully selected patients with hypertrophic cardiomyopathy.
Read MoreOct 25, 2024
The H2FPEF score, a prognostic tool for diagnosing heart failure with preserved ejection fraction, proved useful for risk stratification in HCM.
Read MoreOct 24, 2024
Comorbid hypertension in patients with hypertrophic cardiomyopathy was an independent risk factor for reduced left ventricle fraction and strain.
Read MoreOct 24, 2024
Researchers identified ECG patterns to help clinicians distinguish apical HCM from Wellens’ syndrome, Takotsubo cardiomyopathy, and intracranial processes.
Read MoreOct 23, 2024
Patients with HCM who had elevated left ventricular outflow tract gradients on echocardiography also had significantly lower quality of life scores.
Read MoreOct 22, 2024
A research team from the Mayo Clinic externally validated an AI electrocardiography algorithm that detects hypertrophic cardiomyopathy with high accuracy.
Read MoreSep 30, 2024
4D flow MRI may be a viable, non-invasive alternative to right heart catheterization for measuring blood flow in patients with pulmonary arterial hypertension.
Read MoreSep 30, 2024
New findings shed light on optimal pre-surgical myectomy for obstructive hypertrophic cardiomyopathy imaging techniques and measurement types.
Read MoreSep 29, 2024
Per-segment indexed apical wall thickness thresholds were accurate in detecting apical hypertrophy and could help diagnose apical hypertrophic cardiomyopathy.
Read MoreSep 28, 2024
A study published in ESC Heart Failure identified seven influencing factors and two prognostic factors for end-stage hypertrophic cardiomyopathy.
Read MoreSep 27, 2024
Type 2 diabetes impacted left ventricular and atrial function in patients with hypertrophic cardiomyopathy, emphasizing the need for diabetes surveillance.
Read MoreAug 25, 2024
Matthew Budoff, MD, reviews key points from the 2024 HCM guidelines, including recreational exercise, AF, and ICD risks, and discusses the possible impacts.
Read MoreAug 24, 2024
High FIB-4 scores were linked to heightened risks for cardiovascular comorbidities, cardiac death, and MACE in patients with hypertrophic cardiomyopathy.
Read MoreAug 23, 2024
Percutaneous intramyocardial septal radiofrequency ablation was efficacious and safe for patients with obstructive hypertrophic cardiomyopathy.
Read MoreAug 21, 2024
Personalized distal ventricular pacing therapy reduced obstruction and improved exercise performance in patients with HCM with refractory, symptomatic LVMCO.
Read More